Volume 6, Issue 6, Pages (June 2005)

Slides:

Advertisements

Similar presentations

Crohn's disease Prof Daniel C Baumgart, MD, Prof William J Sandborn, MD The Lancet Volume 380, Issue 9853, Pages (November 2012) DOI: /S (12)

Advertisements

Volume 17, Issue 11, Pages (November 2016)

Fever of unknown origin and cancer: a population-based study

Volume 14, Issue 12, Pages (November 2013)

Volume 14, Issue 4, Pages (April 2013)

Volume 16, Issue 8, Pages (August 2015)

Volume 12, Issue 9, Pages (September 2011)

Volume 357, Issue 9273, Pages (June 2001)

Volume 17, Issue 12, Pages (December 2016)

Volume 16, Issue 2, Pages (February 2015)

Volume 356, Issue 9239, Pages (October 2000)

Raltegravir for the treatment of patients co-infected with HIV and tuberculosis (ANRS Reflate TB): a multicentre, phase 2, non-comparative, open-label,

Volume 370, Issue 9605, Pages (December 2007)

Volume 8, Issue 3, Pages (March 2007)

Volume 359, Issue 9322, Pages (June 2002)

Volume 12, Issue 11, Pages (October 2011)

Erlotinib or Docetaxel for Second-Line Treatment of Non-small Cell Lung Cancer: A Real-World Cost-Effectiveness Analysis Ian Cromwell, MSc, Kimberly.

Intravenous or nebulised magnesium sulphate versus standard therapy for severe acute asthma (3Mg trial): a double-blind, randomised controlled trial

Volume 14, Issue 4, Pages (April 2013)

Volume 377, Issue 9783, Pages (June 2011)

Volume 13, Issue 12, Pages (December 2012)

Volume 373, Issue 9666, Pages (March 2009)

Volume 371, Issue 9611, Pages (February 2008)

Volume 366, Issue 9482, Pages (July 2005)

Volume 13, Issue 3, Pages (March 2012)

Volume 14, Issue 3, Pages (March 2013)

Volume 366, Issue 9486, Pages (August 2005)

Volume 15, Issue 4, Pages (April 2014)

Volume 15, Issue 2, Pages (February 2014)

Volume 15, Issue 4, Pages (April 2014)

Aspirin in the prevention of cancer – Author's reply

Volume 10, Issue 6, Pages (June 2009)

Volume 366, Issue 9482, Pages (July 2005)

Volume 15, Issue 4, Pages (April 2014)

Volume 373, Issue 9663, Pages (February 2009)

Multimodality Treatment of Stage III Non-small Cell Lung Cancer: Analysis of a Phase II Trial Using Preoperative Cisplatin and Gemcitabine with Concurrent.

Volume 9, Issue 10, Pages (October 2008)

Volume 375, Issue 9732, Pages (June 2010)

Volume 18, Issue 3, Pages (March 2017)

Volume 15, Issue 1, Pages (January 2014)

Phase II Trial of Paclitaxel and Cisplatin in Patients with Extensive Stage Small Cell Lung Cancer: Cancer and Leukemia Group B Trial 9430 Thomas E.

Volume 13, Issue 12, Pages (December 2012)

Volume 19, Issue 10, Pages (October 2018)

Volume 14, Issue 6, Pages (May 2013)

Volume 11, Issue 4, Pages (April 2010)

Volume 14, Issue 11, Pages (October 2013)

Volume 385, Issue 9962, Pages (January 2015)

Volume 15, Issue 8, Pages (July 2014)

Intravenous or nebulised magnesium sulphate versus standard therapy for severe acute asthma (3Mg trial): a double-blind, randomised controlled trial

Volume 15, Issue 6, Pages (May 2014)

Volume 14, Issue 6, Pages (May 2013)

Volume 11, Issue 3, Pages (March 2010)

Volume 5, Issue 4, Pages (April 2018)

Volume 16, Issue 8, Pages (August 2015)

Volume 375, Issue 9714, Pages (February 2010)

Volume 15, Issue 8, Pages (July 2014)

Volume 11, Issue 1, Pages (January 2010)

Arlene Chan, Marc Buyse, Bin Yao The Lancet Oncology

Volume 18, Issue 10, Pages (October 2017)

Volume 375, Issue 9715, Pages (February 2010)

Volume 14, Issue 9, Pages (August 2013)

Gemcitabine in Brief versus Prolonged Low-Dose Infusion, both Combined with Cisplatin, for Advanced Non-small Cell Lung Cancer: A Randomized Phase II.

Volume 372, Issue 9632, Pages (July 2008)

Volume 385, Issue 9985, Pages (June 2015)

A Phase III Randomized Trial of Gemcitabine–Oxaliplatin versus Carboplatin–Paclitaxel as First-Line Therapy in Patients with Advanced Non-small Cell Lung.

Volume 14, Issue 7, Pages (June 2013)

Treatment-by-Histology Interaction Analyses in Three Phase III Trials Show Superiority of Pemetrexed in Nonsquamous Non-small Cell Lung Cancer Giorgio.

Volume 371, Issue 9617, Pages (March 2008)

Clinic attendance and disengagement of young adults with type 1 diabetes after transition of care from paediatric to adult services (TrACeD): a randomised,

Volume 371, Issue 9611, Pages (February 2008)

Presentation transcript:

Volume 6, Issue 6, Pages 369-376 (June 2005) Gemcitabine versus cisplatin, epirubicin, fluorouracil, and gemcitabine in advanced pancreatic cancer: a randomised controlled multicentre phase III trial Dr Michele Reni, MD, Stefano Cordio, MD, Carlo Milandri, MD, Paolo Passoni, MD, Elisa Bonetto, MD, Cristina Oliani, MD, Gabriele Luppi, MD, Roberto Nicoletti, MD, Laura Galli, MSc, Roberto Bordonaro, MD, Alessandro Passardi, MD, Alessandro Zerbi, MD, Gianpaolo Balzano, MD, Luca Aldrighetti, MD, Prof Carlo Staudacher, MD, Eugenio Villa, MD, Prof Valerio Di Carlo, MD The Lancet Oncology Volume 6, Issue 6, Pages 369-376 (June 2005) DOI: 10.1016/S1470-2045(05)70175-3 Copyright © 2005 Elsevier Ltd Terms and Conditions

Figure 1 Trial profile The Lancet Oncology 2005 6, 369-376DOI: (10.1016/S1470-2045(05)70175-3) Copyright © 2005 Elsevier Ltd Terms and Conditions

Figure 2 Progression-free survival *One patient died 1 week after randomisation and before starting treatment. The Lancet Oncology 2005 6, 369-376DOI: (10.1016/S1470-2045(05)70175-3) Copyright © 2005 Elsevier Ltd Terms and Conditions

Figure 3 Overall survival *One patient died 1 week after randomisation before starting treatment. The Lancet Oncology 2005 6, 369-376DOI: (10.1016/S1470-2045(05)70175-3) Copyright © 2005 Elsevier Ltd Terms and Conditions